US 11,911,367 B2
Methods for treating cancer
Michael Kyba, Minneapolis, MN (US); and Darko Bosnakovski, Minneapolis, MN (US)
Assigned to REGENTS OF THE UNIVERSITY OF MINNESOTA, Minneapolis, MN (US)
Filed by REGENTS OF THE UNIVERSITY OF MINNESOTA, Minneapolis, MN (US)
Filed on Mar. 10, 2022, as Appl. No. 17/691,305.
Claims priority of provisional application 63/161,255, filed on Mar. 15, 2021.
Prior Publication US 2022/0288032 A1, Sep. 15, 2022
Int. Cl. A61K 31/4184 (2006.01); A61P 35/00 (2006.01)
CPC A61K 31/4184 (2013.01) [A61P 35/00 (2018.01)] 5 Claims
 
1. A method for treating a pediatric sarcoma involving one or more translocations generating an oncogenic fusion transcription factor that requires p300/CBP for activity in a human, comprising administering a compound of formula (I):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof to the human.